Lippis Daniel J. 4

What Happened

Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences (EW), surrendered 432 shares to satisfy a tax liability related to an equity award/option. The shares were disposed at $79.78 each for a total withholding value of $34,465 (reported as a "Payment of exercise price or tax liability" — transaction code F). This was a tax-withholding disposition, not an open-market sale.

Key Details

• Transaction date: 2026-02-22 (reported on Form 4 filed 2026-02-23)
• Price per share: $79.78; Shares surrendered/withheld: 432; Total value: $34,465 (reported)
• Transaction type/code: F — payment of exercise price or tax liability (share withholding)
• Shares owned after transaction: Not specified in this filing (Form 4 notes it reflects changes in beneficial ownership only)
• Filing timeliness: Reported the next day (no late filing indicated)

Context

• Code F transactions typically reflect shares withheld to cover taxes after an option exercise or restricted stock vesting; they are routine administrative events and do not necessarily signal the insider's view on the company stock.
• This was a withholding/surrender of shares for taxes (not a market sale or new purchase).